CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
68.63
-1.17 (-1.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
CONMED Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CONMED stock have an average target of 82.83, with a low estimate of 71 and a high estimate of 98. The average target predicts an increase of 20.69% from the current stock price of 68.63.
Analyst Consensus: Buy
* Price targets were last updated on Oct 31, 2024.
Analyst Ratings
The average analyst rating for CONMED stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $97 | Strong Buy | Reiterates | $97 | +41.34% | Oct 31, 2024 |
| Needham | Needham | Strong Buy Reiterates $97 | Strong Buy | Reiterates | $97 | +41.34% | Oct 4, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $95 → $80 | Buy | Maintains | $95 → $80 | +16.57% | Aug 1, 2024 |
| Stifel | Stifel | Strong Buy Maintains $88 → $76 | Strong Buy | Maintains | $88 → $76 | +10.74% | Aug 1, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $77 → $71 | Hold | Maintains | $77 → $71 | +3.45% | Aug 1, 2024 |
Financial Forecast
Revenue This Year
1.33B
from 1.24B
Increased by 6.69%
Revenue Next Year
1.43B
from 1.33B
Increased by 7.45%
EPS This Year
4.11
from 2.04
Increased by 101.59%
EPS Next Year
4.94
from 4.11
Increased by 20.01%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.4B | 1.5B | 1.6B | |
| Avg | 1.3B | 1.4B | 1.5B | |
| Low | 1.3B | 1.4B | 1.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 10.0% | 11.7% | 12.4% | |
| Avg | 6.7% | 7.5% | 6.6% | |
| Low | 2.4% | 1.8% | 0.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 4.24 | 5.25 | 6.21 | |
| Avg | 4.11 | 4.94 | 5.70 | |
| Low | 3.94 | 4.47 | 5.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 107.9% | 27.7% | 25.7% | |
| Avg | 101.6% | 20.0% | 15.4% | |
| Low | 93.1% | 8.7% | 2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.